Norepinephrine Completed Phase 3 Trials for Shock, Septic Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01718613Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients
NCT00604019Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock